New article posted on Rare Disease Advisor #MG: "FDA Approves Gefurulimab for Adults With AChR-Positive Generalized Myasthenia Gravis." Read the full article here: https://t.co/q8F34cdhuc #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "In Vivo CAR T-Cell Therapy Advances to MG and MS Trials After Promising Early Findings." Read the full article here: https://t.co/WIhTOicusH #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "IVIG, Nonsteroidal Immunosuppressant Use Linked to Higher MG Exacerbation Odds." Read the full article here: https://t.co/KT6qklhA0V #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Why Interpreting Services Are Critical to MG Care." Read the full article here: https://t.co/lX05ozWEZv #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Phenotype May Outperform MGFA Severity in Predicting MG Relapse After Thymoma Resection." Read the full article here: https://t.co/M1I3URw1pG #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "MuSK-Positive Myasthenia Gravis Age of Onset Is Skewing Older." Read the full article here: https://t.co/b6WW2CNj9i #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "China Approves Subcutaneous Batoclimab for AChR-Positive Generalized Myasthenia Gravis." Read the full article here: https://t.co/jH93Ma2dDp #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "How Telehealth Is Reshaping Myasthenia Gravis Care." Read the full article here: https://t.co/NLU2y1dvAT #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Early Steroid Pulse Therapy Speeds Relief in Ocular Myasthenia Gravis." Read the full article here: https://t.co/GpI72n9TCc #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "How My Momβs MG Diagnosis Changed Our Relationship Forever." Read the full article here: https://t.co/5tMML7snFw #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "CAR T-Cell Therapy Consensus Recommendations Updated for MG and Other Autoimmune Diseases." Read the full article here: https://t.co/t145DXt0Rj #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Cizutamig Shows Clinical and Immunologic Activity in Generalized MG: Interim Phase 1b Data." Read the full article here: https://t.co/jw2HclU9WA #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "CORE-5 Social Risk Screening Tool Reveals Unmet Needs in Black Patients With Generalized MG." Read the full article here: https://t.co/hlCzcKuEIQ #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Indirect Comparisons Favor Zilucoplan Over Other C5 Inhibitors, IVIG in Generalized MG." Read the full article here: https://t.co/OSgHX308fV #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Meningococcal Infections Remain Rare in US Patients Receiving C5 Inhibitors for MG or NMOSD." Read the full article here: https://t.co/62UwOZcRAM #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "CAR T-Cell Therapy Mivocabtagene Autoleucel Shows Sustained Benefits for Up to 1.5 Years in MG." Read the full article here: https://t.co/uhmipu2mp5 #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Ravulizumab and Eculizumab Reduce Steroid Use and MG-Related Hospitalizations: Real-World Data." Read the full article here: https://t.co/RetVsNjrSn #MyastheniaGravis#neurology#raredisease
New article posted on Rare Disease Advisor #MG: "Short Social Media Videos About Myasthenia Gravis Often Lack Reliability." Read the full article here: https://t.co/TDVHt5c65R #MyastheniaGravis#neurology#raredisease